EntreChem's kinase inhibitor shows potential for treatment of head and neck cancer
March 26th, 2012 - Oviedo (Spain)
The results of a public-private collaborative research from EntreChem SL (Oviedo) and CIEMAT (Research Center for Energy, Environment and Technology, in Madrid) focused on searching for a new strategy for Head and Neck Squamous Cell Carcinoma…
|
EntreChem's developmental drug opens the door to a new strategy for glioblastoma
May 9th, 2011 - Oviedo (Spain)
A multidisciplinar research team from EntreChem SL (Oviedo), Valdecilla Hospital (Santander), University of Cantabria (Santander) and Universiy of Navarra's CIMA (Center for Applied Medical Reseach, Pamplona) has developed a new strategy…
|
Dr Jesús Cortés joins EntreChem as Director of Molecular Biology
December 30th, 2010 - Oviedo (Spain)
EntreChem announces that Dr Jesús Cortés has joined the company as Director of Molecular Biology…
|
EntreChem SL closes financing round to develop new molecules for oncology
September 16th, 2010 - Oviedo (Spain)
EntreChem closed a financing round thanks to a mix of private and public funding, in a deal that significantly strengthens the capacities…
|
AENOR grants EntreChem UNE-166002 certification, an standard for the implementation of a quality R&D management system
February 4th, 2010 - Oviedo (Spain)
AENOR (Spanish Association for Standarization and Certification) has granted EntreChem with the UNE-166002 certification…
|
EntreChem awarded NEOTEC-2 financing from CDTI
June 25th, 2009 - Oviedo (Spain)
The Centre for the Development of Industrial Technology (CDTI) has awarded EntreChem with a NEOTEC-2 grant…
|
EntreChem study selected for poster presentation at the 20th EORTC-NCI-AACR symposium on "Molecular Targets and Cancer Therapeutics"
held in Geneva from 21-24 October 2008
July 14th, 2008 - Oviedo (Spain)
EntreChem data on the first family of antitumoral molecules being developed by the company have been selected for a poster presentation…
|
EntreChem and Biomar SA enter a collaborative agreement
to develop new compounds
July 31st, 2007 - Oviedo (Spain)
EntreChem has entered a development agreement with Instituto Biomar SA (León, Spain) to exploit EntreChem proprietary technology…
|
EntreChem and Laboratoires Servier sign R&D collaborative agreement
October 25th, 2006 - Oviedo (Spain)
EntreChem has entered a collaborative agreement with Laboratoires Servier (Paris, France) to exploit EntreChem proprietary technology…
|
EntreChem's cofounder interviewed for Nature Biotechnology
Special Report "Biotech in Spain"
September 19th, 2006 - Nature Biothecnology
Dr. Francisco Morís, co-founder and CEO of EntreChem, is interviewed in the September issue of Nature Biotechnology. The issue runs a Special Report about Biotech companies in Spain…
|
C&EN News cover story mentions EntreChem
glycosylation engineering technology
September 4th, 2006 - Chemical & Engineerig News
Professor of biology José Salas and coworkers at the University of Oviedo, Spain, use a different tack. They insert into microorganisms plasmids that endow them with the ability to synthesize novel sugars, which are then transferred to natural products by glycosyltransferases…
|
EntreChem enters financing agreement with CDTI
June 22nd, 2006 - Oviedo (Spain)
EntreChem has signed an agreement with The Centre for the Development of Industrial Technology (CDTI) consisting on a reimbursable loan of 400,000 EUR within the NEOTEC program for promotion of newly created companies focused on technology development…
|
EntreChem secures financing from SRP
April 1st, 2006 - Oviedo (Spain)
EntreChem has signed an agreement with the “Sociedad Regional de Promoción” of the Principality of Asturias for a special loan (a “participative loan”) to finance start-up activities of EntreChem…
|
EntreChem and Genoma España enter a collaborative agreement
January 28th, 2006 - Oviedo (Spain)
EntreChem has signed an agreement with Genoma España, and it has been incorporated to Genoma’s Technology Portfolio. The agreement supports the creation of the company as well as represents an infusion…
|
|
|
|
Antitumorales ‘made in’ Asturias
07-07-2011, El País
Tras la química combinatoria, análogos al poder
21-06-2011, Diario Médico
EntreChem necesita 5 millones para curar el tumor cerebral
31-05-2011, Expansión
Una molécula "made in Asturias"
07-04-2011, La Voz de Asturias
Una empresa asturiana desarrolla un fármaco contra el tumor cerebral
07-04-2011, El Comercio
Descubierta una posible diana contra el gliobastoma cerebral resistente
06-04-2011, Diario Médico
Valdecilla descubre cómo eliminar el tumor cerebral más dañino que existe
03-04-2011, El Diario Montañés
Asturbios, EntreChem y Juntas Industriales y Navales, Premios CEEI
29-11-2010, El Comercio
Apoyos asturianos frente al cáncer
22-08-2010, La Nueva España
La biotecnología tiene mucha vida
05-01-2010, La Nueva España
Dos proyectos que superan los límites de la Universidad
15-11-2009, El Comercio
La gran batalla de las ‘spin-offs’
23-02-2009, El Comercio
La investigación asturiana quiere tener crédito
08-12-2008, La Nueva España
Convertir tecnología académica en productos con aplicación en el mundo real
01-10-2008, Fórmula Emprendedores
Excelencia en innovación
26-04-2008, La Nueva España
EntreChem y Bioingetec, nuevas empresas de Biotecnología
15-01-2006, El Comercio
Francisco Morís, químico y director de la primera empresa de biotecnología
12-01-2006, La Voz de Asturias
Francisco Morís dirige la primera empresa en el seno de la Universidad
12-01-2006, La Nueva España
Una forma alternativa de generar riqueza industrial en Asturias
21-12-2005, La Nueva España
EntreChem hará fármacos y productos de valor añadido
02-12-2005, La Nueva España
Genoma España avala el proyecto de patente de la Universidad
02-12-2005, La Voz de Asturias
|
|
